Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
4-Apr-2023
Kazia presents new data at AACR Annual Meeting
21-Mar-2023
Change of Director's Interest Notice
17-Mar-2023
Change of Director's Interest Notice
8-Mar-2023
Notification of cessation of securities - KZA
7-Mar-2023
Clinical Collaboration for Phase II clinical study
7-Mar-2023
Change in substantial holding
6-Mar-2023
Change in substantial holding
6-Mar-2023
Change of Director's Interest Notices
6-Mar-2023
Notification regarding unquoted securities - KZA
3-Mar-2023
Cleansing Notice
Previous
1
2
3
4
5
Next
